QUADRIGA BIOSCIENCES INC has a total of 44 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Japan and Australia. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are PROPHIN LAB SPA, NANJING HERON PHARMACEUTICAL SCIENCE AND TECH CO LTD and GRINDEKS JOINT STOCK COMPANY.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | Japan | 4 | |
#3 | Australia | 3 | |
#4 | China | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Taiwan | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Canada | 2 | |
#9 | Israel | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Singapore | 2 | |
#12 | Argentina | 1 | |
#13 | Hong Kong | 1 | |
#14 | Mexico | 1 | |
#15 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Koller Kerry J | 36 |
#2 | Jandeleit Bernd | 36 |
#3 | Fischer Wolf-Nicolas | 34 |
#4 | Ringold Gordon | 13 |
#5 | Bernd Jandeleit | 5 |
#6 | Kerry J Koller | 5 |
#7 | Wolf-Nicolas Fischer | 3 |
#8 | Fischer Wolf Nicolas | 2 |
#9 | Wolf Nicolas Fischer | 1 |
#10 | Gordon Ringold | 1 |
Publication | Filing date | Title |
---|---|---|
US2016346240A1 | Methods of chemotherapy using chemotherapeutic agents based on beta-substituted beta-amino acids and analogs | |
EP3331851A1 | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof | |
WO2015117146A1 | Beta-substituted gamma-amino acids and analogs as chemotherapeutic agents | |
CN106163509A | Substituted beta amino acids of β as chemotherapeutics and the like |